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We  conducted a wide-ranging review of the literature regarding osteochondral lesions of
the ankle, with the aim of presenting the current concepts, treatment options, trends and
future perspectives relating to this topic.
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Introduction
Lesions of chondral and osteochondral tissues of the ankle are
commonly related to ankle sprain,1 which affects one in every
10,000 individuals in the United States daily.
Although there is relative agreement in the literature
regarding the microtraumatic etiology of osteochondral
lesions of the talus, when the focus of attention shifts to the
diagnosis and treatment, this becomes a controversial and
extremely dynamic subject, which justify the interest to elab-
orate the present study, whose main objective was to update
the diagnostic and therapeutic approaches of these injuries.
Material  and  methods
This review and update article assessed studies related to the
treatment of osteochondral lesions that affect the ankle joint.
Prospective and randomized studies, case series, and system-
atic reviews were included.
Diagnosis
The suspected diagnosis of osteochondral lesions of the talus
starts with complaints of pain related to physical activities,
usually with a history of previous trauma. Joint swelling,
sensation of instability, joint blockage, or extremely painful
clamping may occur.
Despite the aforementioned complaints, physical exami-
nation is rather vague and is limited to diffuse tenderness of
Fig. 1 – Axial computed tomography allows for the identiﬁcation
osteochondral lesions of the talus. The lower images correspond1 6;5 1(5):489–500
the joint during ﬂexion and maximum extension, and touch-
sensitive areas on the tibiotalar joint line.
Testing ankle stability is essential for the diagnosis of insta-
bility, which is frequently associated with or is the main cause
of the osteochondral ankle injury.
Despite the great chance of false-negative diagnoses, sim-
ple ankle radiographs in AP, lateral, and oblique are the ﬁrst
imaging to be obtained in the diagnostic process of osteochon-
dral lesions of the talus.2
The most common ﬁnding in simple radiology is the pres-
ence of poorly deﬁned radiolucent area in the talar dome,
in the place where the pathological process has become
installed.
The main limitation of computed tomography (CT) is the
inability to provide data on the quality of the articular carti-
lage; however, it is the main resource in the evaluation of bone
changes associated with injury, measurement, and location,
as well as in the deﬁnition of the deviations of the fragments,
and therefore it has the ability to classify the lesions3 (Fig. 1).
Magnetic resonance imaging (MRI) provides information,
allowing for the assessment of articular cartilage and presence
of subchondral inﬂammatory changes, as well as for the iden-
tiﬁcation of the depth of the chondral lesion.4,5 It is therefore
regarded as the gold standard in the diagnosis of osteochon-
dral lesions6,7 (Fig. 2).
The most widespread classiﬁcation for osteochondral
lesions of the talus is that proposed by Berndt and Harty8 in
1959; it is based on the degree of displacement of the osteo-
chondral fragment and has four stages: Stage I – small focal
subchondral trabecular compression area; Stage II – partially
loose fragment (incomplete fracture); Stage III – loose fragment
, measurement, and accurate classiﬁcation of
 to three-dimensional reconstruction.
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Fig. 2 – X-rays of the ankle and magnetic resonance imaging of a patient who underwent arthroscopic treatment with
debridement and microfractures.
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tcomplete fracture), but not displaced; and Stage IV – loose
ragment (complete fracture) and displaced from its bed.
In 2001, Scranton and McDermott9 added Stage V to the
lassiﬁcation of Berndt & Harty, characterized by the presence
f osteochondral cysts with a size corresponding to that of the
riginal injury, just below the damaged articular surface.
Mintz et al.4 combined arthroscopic observations with MRI
o design their rating for osteochondral lesions of the talus,
ollowing the same dynamics of the other classiﬁcations. Six
ifferent stages are possible: Stage 0 – normal cartilage; Stage
 – hypersignal cartilage on MRI, but normal arthroscopic
ppearance; Stage 2 – ﬁbrillation and cracks that do not reach
he bone; Stage 3 – presence of cartilage ﬂap, with exposure of
he subchondral bone; Stage 4 – loose fragment, non-diverted;
tage 5 – diverted fragment.
Despite the known possibility of overestimation of injuries,
here is a clear and well-deﬁned trend in the literature to value
mages of osteochondral lesions of the talus obtained by MRI,10
specially those of high-resolution,11 due to their excellent
orrelation with arthroscopic ﬁndings, a fact which greatly
elps in therapy planning and prognosis.
rognostic  factorsize
urrently, there appears to be a consensus on the indica-
ion of arthroscopic treatment for osteochondral lesions ofthe talus smaller than 1.5 cm2, even for recurrent lesions.11–13
The recommended arthroscopic treatment is debridement of
the injured area, with resection of free or partially-detached
osteochondral fragments, followed by stimulation of the bone
marrow through drilling or microfractures of the subchondral
bone.14,15
Location
The location of the lesions inﬂuences the prognosis much
more  due to the reparative tissue stability (retention) than to
the area or the quadrant in which the lesion is positioned.
It is known that lesions located in the rounded areas of the
articular surface, also known as talar shoulders, offer more
precarious conditions to stabilize the repair tissue – uncon-
tained injuries – and therefore they have a less favorable
prognosis.12,16
Without good quality edges, the scar that forms is less
stable, increasing the chances of mechanically unfavorable
formation of ﬁbrocartilage,17 rich in type I collagen.
Age
The patient’s age at the onset of the injury is considered to
18be an important prognostic factor. However, there is con-
troversy over this claim, as some authors failed to observe
differences in results when considering only age, having
denied this correlation.18,19
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Subchondral  cysts  and  depth
The occurrence of subchondral cystic lesions indicates poor
prognosis.9,20 Poor results can be expected in 53% of patients
in this group.21–23
Other  possible  prognostic  factors
Chondral  lesions  vs.  osteochondral  lesions
Through the observation of 283 patients for an average of 52
months, Choi et al.24 observed no differences in the prognosis
of injuries that involved only the chondral layers from those
that surpassed the subchondral bone plate.
Bodyweight  load  support
While some authors believe that early loading does not inter-
fere with the ﬁnal result of small osteochondral lesions,25 Gill
et al.26 histologically demonstrated that maintenance of load
limitation in the postoperative period deﬁnitively inﬂuences
the ﬁlling speed and the quality of the repair tissue in osteo-
chondral lesions.
Spinal  cord  edema
The clinical picture and the prognosis of osteochondral lesions
are inversely related to the intensity of bone marrow edema
observed in the MRI.27
Joint  instability  and  trauma28
Treatment.  The treatment of osteochondral lesions of the
talus should be restricted to symptomatic lesions. The
occasional ﬁnding of asymptomatic osteochondral lesions,
regardless of location, type, and size, should be communi-
cated to the patient or his/her relatives; the case should be
followed-up at regular intervals in search of possible joint
deterioration.29
Conservative  treatment.  The non-surgical treatment modali-
ties available in the literature include modiﬁcation of activities
of daily living, intra-articular steroid inﬁltration, use of
orthotics, load suppression, and use of immobilizing boots and
orthoses.8,11
The results of this type of treatment do not exceed 45%30;
it is neither consistent nor predictable.31
The plasma rich in growth factors is a form of PRP con-
sidered to be a biological carrier of a complex mixture of
bioactive proteins essential to the normal healing process,
having potential effects on the repair of osteochondral lesions
and arthrosis.32,33 These ﬁndings and therapeutic applications
still require further studies to consolidate their applicability in
daily practice.
Surgical  treatment.  Surgical treatment of osteochondral
ankle injuries can be divided into ﬁve main groups of
procedures17,34:
1. Reduction and ﬁxation of osteochondral fragments
2. Bone marrow stimulation
3. Articular cartilage replacement
4. Regenerative cell therapy
5. Metal implants1 6;5 1(5):489–500
Reduction  and  ﬁxation  of  osteochondral  fragments
Acute osteochondral fractures are produced mostly by injuries
after ankle inversion.
Under these conditions, patient should be treated with
urgency and, when feasible, the fragments should be reduced
and set in their original bed. The procedure can be done
arthroscopically and the fragments can be ﬁxed with ﬁxation
darts or absorbable screws, as both of which provide excellent
functional results.
Smaller or devitalized fragments are resected, and the base
of the lesion is treated by stimulating the bone marrow.
Despite the good prognosis for fracture consolidation, a
deterioration of the cartilage that covers the fragments can
be expected in one-third of the cases.
Bone  marrow  stimulation
If the articular cartilage has only softened zones (chondroma-
lacia) or ﬁbrillation without exposure of the subchondral bone,
and there is good stability of the tissue, surface debridement
and “chondral sealing” with the use of radiofrequency can be
performed.35
Anterograde  drilling  and  microfractures
The rationale behind multidrilling or microfractures for the
treatment of osteochondral lesions of the talus is based on the
perforation of the subchondral bone, allowing the contact of
the bone marrow with the lesion. In addition to the migra-
tion of multipotent mesenchymal cells into the bed of the
wound, local neovascularization is also induced, with cellular
afﬂux to the repair zone. Some basic rules must be followed
to ensure the success of these procedures: (1) the edges of the
lesion should be curetted and the softened tissue should be
removed until the healthy cartilage, ﬁrmly adhered to the sub-
chondral bone, is reached; (2) the edges should be as regular
and perpendicular as possible; (3) drilling or microfractures in
the subchondral bone must be made perpendicularly to the
surface at 3–4-mm intervals; (4) the depth should be at least
3 mm to ensure that the subchondral bone has been crossed;
and (5) the procedure should be started in the periphery of the
lesion and ﬁnish in the center29 (Fig. 3). The ﬁnding of bleed-
ing in the base of the injury from the subchondral capillary is
essential. The blood that is deposited in the base of the lesion
contains progenitor cells and cytokines responsible for initi-
ating the healing process, which involves the formation of a
ﬁbrin clot and subsequent formation of ﬁbrous scar tissue that
will undergo metaplasia into ﬁbrocartilaginous tissue (Fig. 4)
with less resistance to compression and shear forces when
compared with the normal articular cartilage tissue.
A systematic review demonstrated the consistency of the
results obtained with the treatment of osteochondral lesions
through debridement and microfractures, with mean AOFAS
score of 86.8 points, achieving 80.2% excellent and good
results36; however, signiﬁcant deterioration of results was
observed after 4.2 years of the procedure.17In a more  recent meta-analysis, the success of combin-
ing excision of fragments, curettage of the base of the injury,
and bone marrow stimulation was 85%, compared with 32%
good results from isolated fragment excision and 77% good
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Fig. 3 – Drilling in the base of osteochondral lesions of the talus.
Fig. 4 – Microfractures in the base of osteochondral lesions of the talus.
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results from excision combined with curettage of the base of
the injury.37
The repetition of the debridement process, curettage, and
bone marrow stimulation in patients with unfavorable evolu-
tion reached 92% good results, characterized by return to prior
sporting activities, including professional activity.38
The result of microfractures can be enhanced by
hyaluronate intra-articular injection immediately after
surgery, with improved function and pain results when
compared to patients who  did not receive such treatment.39
Animal models using platelet-rich plasma in conjunction
with bone marrow stimulation procedures showed better
repair of the joint cartilage when compared with isolated sur-
gical procedure, although hyaline cartilage was not obtained in
the ﬁnal result.40 The same is true for the use of bone marrow
aspirate concentrate.41
Retrograde  drilling
Retrograde drilling with radiographic control is considered to
be a very effective treatment option for osteochondral lesions
of the intact joint cartilage.41 After placing a guidewire in the
lesion with the aid of ﬂuoroscopy and arthroscopy, a cannu-
lated drill is passed over this guidewire and never exceeds the
intact cartilage. Through the tunnel formed, it is possible to
place the bone graft to ﬁll the lesion. Currently, various mod-
els of articulated and extremely efﬁcient guiding instruments
help the surgeon to locate the lesion and reach it safely.
Articular  cartilage  replacement
Autologous  osteochondral  graft
The osteochondral autologous grafting system known as
mosaicplasty involves obtaining cylindrical cartilage and bone
grafts, most commonly originating from the lateral femoral
condyles, and transferring them to areas of osteochondral
Fig. 5 – MRI  scans obtained six months a1 6;5 1(5):489–500
lesion in the loading surface of the talar dome. This procedure
presents encouraging results.
The indications for osteochondral grafting comprise
lesions larger than 1.5 cm2, recurrent or refractory to more
conservative treatment methods, and especially lesions asso-
ciated with subchondral cysts.42
Mosaicoplasty has technical standards that must be fol-
lowed in order to achieve better results: (1) the donor area
can never be a load bearing region; (2) osteochondral cylinders
must be inserted perpendicularly to the receiving surface; (3)
the cartilage portion should have the shape and curvature as
close to the receiving zone as possible; (4) the cylinder must
be at least 15 mm in length for chondral lesions and 25 mm in
the presence of subchondral cysts; (5) the cartilage plug must
remain perfectly leveled with the edges of the receiving region;
steps or unevenness regarding the neighboring cartilage are
not acceptable29,43 (Fig. 5).
Following the indications for each procedure, the results of
osteochondral autologous grafts are superior to the combina-
tion of debridement and microfractures.44
The number of grafts used, previous procedures, the need
for osteotomy of the malleolus, and the presence of mild
osteoarthritis of the affected joint do not inﬂuence the ﬁnal
outcome of this procedure.
Regarding the donor area, the most frequent residual
symptoms are a feeling of instability during activities of daily
living and pain, present in 11% of patients who  underwent
surgery.45 The occurrence of these symptoms is related to very
large parapatellar incisions and exaggerated tensioning dur-
ing the closure. The knee prognosis does not appear to be
affected by the number of removed grafts, graft size, or age
of the patient.46Osteochondral  allograft
When osteochondral lesions exceed 3 cm2, become uncon-
tained, affect the shoulder of the talus, or are accompanied
fter autologous osteochondral graft.
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Fig. 6 – Osteochondral homograft used for the treatment of extensive medial talar shoulder injury (The authors thank Dr.
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y large subchondral cysts, osteochondral autografts present
echnical difﬁculties, with a greater chance of poor results.
n such cases, fresh cadaver allograft, with viable chondro-
ytes and normal subchondral bone, appears as an interesting
ption, especially because it does not present morbidity in
he donor area or areas without coverage between the grafted
lugs47 (Fig. 6).
Cryopreservation leads to a signiﬁcant decline in the num-
er of viable chondrocytes. The cell survival falls to 20–30% in
wo weeks, the period during which the procedure should be
one.
Despite the perspective of good results, the method has
ome main obstacles: the transmission of diseases, the pos-
ibility of adverse immune reaction, and difﬁculty in graft
ncorporation into the bed.
There is consensus among the authors to consider the
steochondral allograft as a salvage treatment for large lesions
nd for those where other methods have failed repeat-
dly. However, the high incidence of procedure failure (30%)
nd of secondary procedures (40%) should be taken into
ccount.48,49
egenerative  cell  therapyutologous  chondrocyte  implantation
he procedure begins by obtaining viable chondrocytes
hrough resection of a small fragment of the healthy cartilage
issue from the joint to be treated or from another joint fromthe same individual. The chondrocytes are isolated and cul-
tured for three to six weeks in order to multiply. The second
part of the procedure is the preparation of the receiving area
and the implantation of the cultured cells.50 Curettage and
debridement of the base and edges of the injury until they
establish the limits of healthy cartilage, ﬁrmly adhered to the
subchondral bone, are an integral part of this process. Possible
subchondral cysts are ﬁlled with cancellous graft and perios-
teum blades in the appropriate dimensions which are sutured
and glued with ﬁbrin to the edges of the lesion, in order to
create an airtight chamber, inside which the cultured cells are
implanted (Fig. 7).
Indications for this therapy include recurrent osteochon-
dral lesions of any size and primary treatment of larger lesions
than 2.5 cm2 with or without subchondral cysts in patients
aged between 15 and 55 years, without degenerative arthritis
or mirror-image osteochondral lesions, and without instability
or changes in joint alignment.51
The complications, especially those related to periosteal
hypertrophy and delamination of the membranes used in
wound coverage, reach 18–33% of cases.52
In order to reduce morbidity and the technical difﬁculty of
autologous chondrocyte implantation, various attempts have
been made regarding the carrier for cultured chondral cells.A combination of ﬁbrin and thrombin (Chondron, Sewon
Cellontech Co., Seoul, South Korea), to which the cultured
chondrocytes are added for implantation in the receiving area
of the talus, can be used.53
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The use a combination of collagen membranes with MSC,
bone marrow concentrate (BMC), and bone marrow-derivedFig. 7 – Autologous chondrocyte
The second generation of autologous chondrocyte trans-
plants involves the use of collagen membranes for carrying
the cells, which eliminates the need for obtaining the perios-
teum and all the difﬁculties and complications inherent to
this period of the operation, and the results obtained are
encouraging.54
The autologous chondrocyte implantation through an
arthroscopic procedure was a step forward. This achieve-
ment was only possible due to the use of a ﬂexible collagen
membrane called matrix-induced autologous chondrocyte
implantation (MACI).55
Mesenchymal  stem  cells
Stem cell therapy is based on two mechanisms of action. At
ﬁrst, the cells differentiate and mimic  the ﬁnal cells of tis-
sues and organs; then, there is the production of substances
(cytokines and growth factors) that favorably inﬂuence the
angiogenesis and the reduction of cell apoptosis, and induce
the endogenous regeneration.
Giannini et al. demonstrated the efﬁciency of the use of
stem cells obtained from concentration of aspirated bone mar-
row or bone marrow-derived cell transplantation (BMDCT) in
clinical trials,56 albeit with a possible tendency toward deteri-
oration of the results.57
Stem cells derived from fat have a better potential for
chondrogenesis58; those obtained from the synovium appar-
ently have good differentiation into chondrocytes, but only in
animal studies.59
Intra-articular injection of mesenchymal stem cells (MSC)
favorably inﬂuenced the results of treatment of patients older
than 50 years with lesions larger than 109 mm2 associatedlantation (sandwich technique).
with subchondral cysts, and may have some beneﬁt in low-
ering the speed of evolution to degenerative disease.
Chondrogenesis  induction  by  autologous  matrixFig. 8 – Particulated juvenile cartilage. (The authors thank
Dr. Rebecca Cerrato – Mercy Hospital, Baltimore, USA – for
the authorization to use these ﬁgures).
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SC  (BMSC) has been shown to be more  advantageous than
hondrocyte implantation.57
In the matrix-induced chondrogenesis technique, autol-
gous chondrocytes (matrix-associated autologous chondro-
yte transplantation/implantation [MACT/MACI]) are seeded
nto a type I and III acellular collagen matrix that is placed
n the clot formed after microfracture to provide a favorable
nvironment for chondral regeneration. Clinical results with
ve years of follow-up are encouraging.60articulated  juvenile  articular  cartilage
timulation of osteochondral talar lesions repair can be
ade from the articular cartilage of children and adolescents
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cadavers, particulated into 1-mm cubes implanted in the pre-
viously prepared bed of the lesion (DeNovo Natural Tissue,
Zimmer Inc., Warsaw, USA). After arthroscopical debridement
and preparation of the lesion, the saline ﬂow is interrupted
and the injury is dried. A thin layer of ﬁbrin glue is applied
across the extent of chondral lesion and the particulate carti-
lage is inserted to cover the full osteochondral defect. A new
ﬁbrin layer is applied over the region so as to increase the
stability of the graft. Studies with animal models and short-
term follow-up in patients have shown good results, with the
formation of hyaline cartilage in the defects (Fig. 8).
The initial clinical results are good61; in lesions smaller
than 1.5 cm2 the success rate reaches 92% good results.62
Osteochondral injury 
of the ankle
al / simple RX / CT / MRI
Symptomatic? Yes
Detached 
fragment? Articular 
surface
Articular cartilage intact?
o
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allograft
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ondral 
ts
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ndral lesions of the talus, based on the literature.
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Metal  implants
Filling of the talar osteochondral lesion area with the use
of metallic implants – surface prostheses – aims to redo the
contour of the injured area and enhance the distribution of
loads on the ankle joint. It is considered a valid method for
the treatment of osteochondral lesions that are recurrent and
refractory to other forms of treatment.63
Osteochondral  lesions  of  the  distal  tibia
Osteochondral lesions of the distal third of the tibia are
unusual ﬁndings, appearing in 2.6% of all osteochondral ankle
injuries.64
This lower incidence may be related to the concave shape
of the inferior articular surface of the tibia and to the greater
resistance of the tibial cartilage to compression when com-
pared with the talar cartilage.65,66
The treatment of these injuries is more  complex due to the
difﬁculty of access and to the shape of the articular surface
of the tibia. Curettage, excision of fragments, thermal abla-
tion, and stimulation of bone marrow can be done through an
arthroscopic approach.
When cysts are present, ﬁlling with bone graft can be done
through the transmalleolar approach, with arthroscopic assis-
tance.
The consensus among authors is that osteochondral
lesions of the tibia have a worse prognosis than osteochon-
dral lesions of the talus when considering the same physical
characteristics of the lesions.
Assessment  of  the  repaired  cartilage
T2-weighted MRI  mapping is becoming the most useful and
popular resource for the assessment of the repaired artic-
ular cartilage, as an important alternative to arthroscopy,
which is an invasive procedure not free from complications.
As an added advantage, MRI  assessments include the repaired
region as a whole, while arthroscopy has a more  restricted and
superﬁcial ﬁeld of vision than a local biopsy would provide.67
The integration of the Mocart morphological scale param-
eters and biochemical mapping through T2-weighted MRI  is
essential for a complete and accurate noninvasive assessment
of the repaired cartilage, improving the interpretation of the
clinical scales. Mapping is suitable for a qualitative assess-
ment of cartilage, being able to distinguish hyaline cartilage
from ﬁbrocartilage and to correlate with clinical outcomes.67
The ﬂowchart (Fig. 9) presents the most common occur-
rences, as well as solutions that are supported in the literature.
Some of the solutions presented are not available in Brazil,
which does not preclude knowledge of them and research
options for patients who  present the problems listed in this
article.Final  remarks
Systematic reviews of the literature, due to the heterogene-
ity of the available studies, do not allow for the deﬁnition of
11 6;5 1(5):489–500
absolute standards of conduct.41 However, there is important
information about the efﬁciency of the treatment methods
with their respective success rates. With this information,
orthopedists are able to support their choices, despite the
lack of mathematical conﬁrmation, until the much-expected
prospective, comparative, well-controlled studies are con-
ducted.
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